Skip to main content
. 2021 Mar 11;11:625461. doi: 10.3389/fcimb.2021.625461

Table 2.

Characteristics of the typical and severe TM patients.

Characteristics Typical cases (n = 134) Matched controls (n = 134) χ2 value P-value Severe cases (n = 66) Matched controls (n = 66) χ2 value P-value
Gender 0.24 0.62 0 1
 Male 110 (82.1%) 113 (84.3%) 50 (75.8%) 50 (75.8%)
 Female 24 (17.9%) 21 (15.7%) 16 (24.2%) 16 (24.2%)
Age (years) 0.22 0.90 3.42 0.07
 18–45 102 (76.1%) 102 (76.1%) 55 (83.3%) 46 (69.7%)
 46–65 30 (22.4%) 29 (21.6%) 11 (16.7%) 20 (30.3%)
 ≥66 2 (1.5%) 3 (2.3%) 0 (0.0%) 0 (0.0%)
CD4+ T cell count (cells/ul) 0.05 0.82 0.34 0.56
 0–50 124 (92.5%) 123 (91.8%) 65 (98.5%) 64 (97.0%)
 51–100 10 (7.5%) 11 (8.2%) 1 (1.5%) 2 (3.0%)
Acute hepatitis co-infection 0.98 0.32 2.88 0.09
 Yes 30 (22.4%) 37 (27.6%) 4 (6.1%) 10 (15.2%)
 No 104 (77.6%) 97 (72.4%) 62 (93.9%) 56 (84.8%)
Other OIs co-infection NA NA NA NA
 Yes 134 (100.0%) 134 (100.0%) 66 (100.0%) 66 (100.0%)
 No 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)

Typical cases, AIDS patients with typical talaromycosis; Severe cases, AIDS patients with severe talaromycosis; OIs, opportunistic infections.